Your browser doesn't support javascript.
loading
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.
Gonzalez, Mayra A; Olivas, Idaly M; Bencomo-Alvarez, Alfonso E; Rubio, Andres J; Barreto-Vargas, Christian; Lopez, Jose L; Dang, Sara K; Solecki, Jonathan P; McCall, Emily; Astudillo, Gonzalo; Velazquez, Vanessa V; Schenkel, Katherine; Reffell, Kelaiah; Perkins, Mariah; Nguyen, Nhu; Apaflo, Jehu N; Alvidrez, Efren; Young, James E; Lara, Joshua J; Yan, Dongqing; Senina, Anna; Ahmann, Jonathan; Varley, Katherine E; Mason, Clinton C; Eide, Christopher A; Druker, Brian J; Nurunnabi, Md; Padilla, Osvaldo; Bajpeyi, Sudip; Eiring, Anna M.
  • Gonzalez MA; Department of Molecular and Translational Medicine, Center of Emphasis in Cancer, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Olivas IM; Department of Molecular and Translational Medicine, Center of Emphasis in Cancer, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Bencomo-Alvarez AE; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Rubio AJ; Department of Molecular and Translational Medicine, Center of Emphasis in Cancer, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Barreto-Vargas C; Department of Molecular and Translational Medicine, Center of Emphasis in Cancer, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Lopez JL; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Dang SK; Immunology Division, University of Guadalajara, Guadalajara, Jalisco, Mexico.
  • Solecki JP; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • McCall E; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Astudillo G; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Velazquez VV; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Schenkel K; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Reffell K; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Perkins M; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Nguyen N; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Apaflo JN; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Alvidrez E; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Young JE; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Lara JJ; Metabolic, Nutrition and Exercise Research (MiNER) Laboratory, Department of Kinesiology, University of Texas at El Paso, El Paso, Texas, USA.
  • Yan D; Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, El Paso, Texas, USA.
  • Senina A; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Ahmann J; L. Frederick Francis Graduate School of Biomedical Sciences, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Varley KE; Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
  • Mason CC; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA.
  • Eide CA; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA.
  • Druker BJ; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA.
  • Nurunnabi M; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA.
  • Padilla O; Huntsman Cancer Institute, The University of Utah, Salt Lake City, Utah, USA.
  • Bajpeyi S; Knight Cancer Institute, Division of Hematology/Medical Oncology, Oregon Health & Science University, Portland, Oregon, USA.
  • Eiring AM; Knight Cancer Institute, Division of Hematology/Medical Oncology, Oregon Health & Science University, Portland, Oregon, USA.
Clin Transl Med ; 12(12): e1146, 2022 12.
Article en En | MEDLINE | ID: mdl-36536477
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Ciclo Celular / Resistencia a Antineoplásicos / Glicerofosfolípidos Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Ciclo Celular / Resistencia a Antineoplásicos / Glicerofosfolípidos Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article